| Title |
Epidemiology of Adverse Drug Reactions in Europe: A Review of Recent Observational Studies
|
|---|---|
| Published in |
Drug Safety, March 2015
|
| DOI | 10.1007/s40264-015-0281-0 |
| Pubmed ID | |
| Authors |
Jacoline C. Bouvy, Marie L. De Bruin, Marc A. Koopmanschap |
X Demographics
The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 1 | 8% |
| Portugal | 1 | 8% |
| Colombia | 1 | 8% |
| United States | 1 | 8% |
| Spain | 1 | 8% |
| Sweden | 1 | 8% |
| Norway | 1 | 8% |
| United Kingdom | 1 | 8% |
| Italy | 1 | 8% |
| Other | 1 | 8% |
| Unknown | 2 | 17% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 9 | 75% |
| Scientists | 2 | 17% |
| Practitioners (doctors, other healthcare professionals) | 1 | 8% |
Mendeley readers
The data shown below were compiled from readership statistics for 507 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Italy | 2 | <1% |
| Spain | 2 | <1% |
| Korea, Republic of | 1 | <1% |
| Unknown | 502 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 98 | 19% |
| Researcher | 53 | 10% |
| Student > Bachelor | 51 | 10% |
| Student > Ph. D. Student | 49 | 10% |
| Student > Doctoral Student | 30 | 6% |
| Other | 87 | 17% |
| Unknown | 139 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 139 | 27% |
| Medicine and Dentistry | 96 | 19% |
| Biochemistry, Genetics and Molecular Biology | 24 | 5% |
| Agricultural and Biological Sciences | 18 | 4% |
| Nursing and Health Professions | 18 | 4% |
| Other | 57 | 11% |
| Unknown | 155 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 November 2023.
All research outputs
#3,324,055
of 26,017,215 outputs
Outputs from Drug Safety
#368
of 1,883 outputs
Outputs of similar age
#40,853
of 282,853 outputs
Outputs of similar age from Drug Safety
#2
of 21 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,883 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.0. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 282,853 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.